Metformin and other antidiabetic agents in renal failure patients.
about
Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic controlUpdate on the treatment of type 2 diabetes mellitusMetformin as a cellular protector; a synoptic view of modern evidencesRisk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.Changes in metformin use in chronic kidney disease.Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions.Therapeutic Concentrations of Metformin: A Systematic Review.Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study.Lactic Acidosis in a Patient with Type 2 Diabetes Mellitus.Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study.Lactic acidosis and severe septic shock in metformin users: a cohort studyPharmacist review prevents evolving metformin-associated lactic acidosis.Treating posttransplantation diabetes mellitus.Metformin associated lactic acidosis (MALA): clinical profiling and management.Could metformin be used in patients with diabetes and advanced chronic kidney disease?Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm.Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient.Lactic acidosis: relationship between metformin levels, lactate concentration and mortality.Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.Therapy: Risk of metformin use in patients with T2DM and advanced CKD.Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?Interpreting the consequences of metformin accumulation in an emergency context: impact of the time frame on the blood metformin levels.Metformin and lactic acidosis during shock: just the tip of the iceberg?Hypoglycemia and severe lactic acidosis in a dog following metformin exposure.Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic Nephropathy.L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides.Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up.Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims dataPost-mortem analysis of lactate concentration in diabetics and metformin poisoningsPrescribing of metformin based on estimated GFR rather than serum creatinine expands the eligible population and is likely safe
P2860
Q26766259-73183290-BD75-4CE1-959A-34AD839087E3Q28073342-58DCB015-9B3B-4761-825A-8C6E25CCCD55Q28817196-4140EC2A-BFBF-4289-B47A-6C0F5C0B3D18Q33705903-7D04E8E0-C2ED-470C-8CE1-FDCA59D071C4Q33783138-9EE2EBBA-CEDD-4B3F-B335-D08E57D8F9D3Q35219625-00B8311A-D8B2-4827-85D6-342EE7760CD0Q35761723-D2DB7597-1106-48A1-B571-5B606F68FCC7Q35841565-8F98A98E-C019-4F98-8902-C718C8F6AFDAQ35922734-EBB3E02F-ED74-4B0A-A659-4EB8F073F5E4Q36420975-9A888A75-4C2F-41C7-9C38-81083CE8EEBAQ36469042-FA4D3BAD-1FC4-4156-9CC4-B332D3C92CFAQ38225699-BAB6E6CC-745A-4BE6-A6C9-E6C19870913AQ38441421-72FA7A4B-086F-45F8-81C5-6DCEF3BC9C91Q38708321-74C00B20-D55C-4989-B465-DF4134497CDCQ38968961-F842BA03-C588-4A1D-A46D-9EB64246FFDDQ39247550-D19AAF3E-631E-4ECA-8034-566FD135B025Q39441009-15381E1A-7464-4D99-ABB2-D8BD3428D817Q39993479-2E87795B-678C-45E7-BDCA-B8BD5020B6D4Q40873693-748A946C-6B61-48FA-8335-A1E90CEBB1C7Q41473546-DAE72973-AB55-489E-A6F3-41F37486319EQ41856389-DAB53AE0-F8D1-4293-9F80-04690E6036A3Q41977578-46AE7039-4713-4F1E-A5D2-AF3E18FDDCFDQ42747325-C36D2528-F593-459C-BF59-096E6D9961B0Q47122838-AB7EDED0-A0F8-45DE-ADA3-64E9FBC69D40Q49216415-4979F7E4-FCCD-4191-8439-8D4811FA6C42Q51677782-200129F1-1BAB-4415-A94F-598C122D8491Q52612546-823E219A-F88E-4497-A16A-6045D206468EQ56888943-03D0C1B5-10FE-4C47-B9BA-E21BC9E64A26Q58800699-BFA31410-96D7-4066-9679-FB2C90FB8195Q58804813-520AD03A-D0FE-4959-A5FF-E8B1B41E5B89
P2860
Metformin and other antidiabetic agents in renal failure patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metformin and other antidiabetic agents in renal failure patients.
@en
type
label
Metformin and other antidiabetic agents in renal failure patients.
@en
prefLabel
Metformin and other antidiabetic agents in renal failure patients.
@en
P2093
P356
P1433
P1476
Metformin and other antidiabetic agents in renal failure patients.
@en
P2093
Jean-Daniel Lalau
Marc E De Broe
Paul Arnouts
P2888
P304
P356
10.1038/KI.2014.19
P407
P50
P577
2014-03-05T00:00:00Z
P5875
P6179
1052864530